Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapy.
Maeda S, Mederos MA, Chawla A, Moore AM, Shoucair S, Yin L, Burkhart RA, Cameron JL, Park JY, Girgis MD, Wainberg ZA, Hines OJ, Fernandez-Del Castillo C, Qadan M, Lillemoe KD, Ferrone CR, He J, Wolfgang CL, Burns WR, Yu J, Donahue TR.
Maeda S, et al. Among authors: girgis md.
Surgery. 2022 May;171(5):1379-1387. doi: 10.1016/j.surg.2021.10.015. Epub 2021 Nov 10.
Surgery. 2022.
PMID: 34774289